The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis presenting to nephrology division, Khyber teaching hospital Peshawar
Keywords:
hemodialysis, CKD-associated pruritus, quality of life (QOL), nephrologyAbstract
Background and Aim: Chronic kidney disease-associated pruritus (CKD-aP), commonly known as uremic pruritus is a frequent and inconvenient disease for patients undergoing hemodialysis. The purpose of the present investigation was to determine the association of CKD-associated pruritus with quality of life in patients undergoing hemodialysis presented to the nephrology division of Khyber Teaching Hospital Peshawar. Patients and Methods: This cross-sectional study was conducted on 227 CKD-associated pruritus patients investigated in the Nephrology Division of Khyber Teaching Hospital Peshawar from March 2022 to February 2023. Patients of either gender (>18 years) undergoing hemodialysis were enrolled. Demographic details, dialysis duration, duration of disease, and various comorbidities conditions were recorded based on a pre-designed questionnaire. Results: Out of 227 patients, there were 142 (62.6%) male and 85 (37.4%) female. The overall mean age was 40.82±6.82 years. The incidence of CKD-associated pruritus was 68.7% (n=156). The presence of various comorbidities such as diabetes mellitus, hypertension, hyperlipidemia, and cardiovascular disease was found in 30 (13.2%), 124 (54.6%), 16 (7.0%), and 6 (2.6%) respectively. The overall mean duration of CKD and duration on hemodialysis was 34.4 [12.0–48.0] months and 22.8 [12.0–36.0] months respectively.
Downloads
References
Rehman IU, Chan KG, Munib S, Lee LH, Khan TM. The association between CKD-associated pruritus and quality of life in patients undergoing hemodialysis in Pakistan: A STROBE complaint cross-sectional study. Medicine. 2019 Sep;98(36).
Ain QU, Asghar MS, Saleem M, Majeed S, Rameez R, Shaukat S. Incidence of Chronic Kidney Disease Related Pruritus and its Relation with Sleep Quality among Patients on Hemodialysis in Pakistan. Pakistan Journal of Medical & Health Sciences. 2022 Apr 12;16(02):1165-.
Daraghmeh M, Badran M, Janajreh A, Hassan M, Taha AA, Koni AA, Zyoud SE. Prevalence of pruritus associated with hemodialysis and its association with sleep quality among hemodialysis patients: a multicenter study. BMC nephrology. 2022 Dec;23(1):1-8.
Rastogi A, Fishbane S, Lerma E. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis. Expert Review of Clinical Pharmacology. 2023 May 4;16(5):387-400.
Haq MU, Khan RA, Munib S, Shahid M, Fahad S. Uremic Pruritus In End-Stage Renal Disease Patients Receiving Three Times Weekly Hemodialysis a Multi-Center Study. Pakistan Journal of Medical & Health Sciences. 2023 Mar 10;17(01):637-.
Song J, Xian D, Yang L, Xiong X, Lai R, Zhong J. Pruritus: Progress toward Pathogenesis and Treatment. Biomed Res Int. 2018;2018:9625936.
Weisshaar E, Szepietowski JC, Dalgard FJ, Garcovich S, Gieler U, Gimenez-Arnau AM, Lambert J, Leslie T, Mettang T, Misery L, et al. European S2k Guideline on Chronic Pruritus. Acta Derm Venereol. 2019;99(5):469–506.
Rehman IU, Lai PSM, Lim SK, Lee LH, Khan TM. Sleep disturbance among Malaysian patients with end-stage renal disease with pruritus. BMC Nephrol. 2019;20(1):102.
Rehman IU, Chohan TA, Bukhsh A, Khan TM. Impact of Pruritus on Sleep Quality of Hemodialysis Patients: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2019;55(10):699.
Silverberg JI, Lai JS, Vakharia PP, Patel K, Singam V, Chopra R, Sacotte R, Patel N, Rastogi S, Kantor R, et al. Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitis. J Am Acad Dermatol. 2020;82(5):1174–80.
Medarov BI, Victorson DE, Judson MA. Patient-reported outcome measures for sleep disorders and related problems: clinical and research applications. Chest. 2013;143(6):1809–18.
Samoudi AF, Marzouq MK, Samara AM, Zyoud SH, Al-Jabi SW. The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine. Health Qual Life Outcomes. 2021;19(1):39.
Voskamp PWM, van Diepen M, Evans M, Caskey FJ, Torino C, Postorino M, Szymczak M, Klinger M, Wallquist C, van de Luijtgaarden MWM, et al. The impact of symptoms on health-related quality of life in elderly pre-dialysis patients: effect and importance in the EQUAL study. Nephrol Dial Transplant. 2019;34(10):1707–15.
Parvan K, Lakdizaji S, Roshangar F, Mostofi M. Quality of sleep and its relationship to quality of life in hemodialysis patients. J Caring Sci. 2013;2(4):295–304.
Satti MZ, Arshad D, Javed H, Shahroz A, Tahir Z, Ahmed MMH, Kareem A. Uremic Pruritus: Prevalence and Impact on Quality of Life and Depressive Symptoms in Hemodialysis Patients. Cureus. 2019;11(7):e5178–e5178.
Edalat-Nejad M, Qlich-Khani M. Quality of life and sleep in hemodialysis patients. Saudi J Kidney Dis Transpl. 2013;24(3):514–8.
Omari AM, Omari LS, Dagash HH, Sweileh WM, Natour N, Zyoud SH. Assessment of nutritional status in the maintenance of haemodialysis patients: a cross-sectional study from Palestine. BMC Nephrol. 2019;20(1):92.
Medarov BI, Victorson DE, Judson MA. Patient-reported outcome measures for sleep disorders and related problems: clinical and research applications. Chest. 2013;143(6):1809–18.
Wang R, Tang C, Chen X, Zhu C, Feng W, Li P, Lu C. Poor sleep and reduced quality of life were associated with symptom distress in patients receiving maintenance hemodialysis. Health Qual Life Outcomes. 2016;14(1):125.
Boivin MJ, Barlow-Mosha L, Chernoff MC, et al. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. Aids 2018;32:189–204.
Khatib ST HM, Hasan SA, Khazneh E, Zyoud SH. Quality of life in hemodialysis diabetic patients: a multicenter cross-sectional study from Palestine. BMC Nephrol. 2018;19:49.
Khan TM, Al-Haider I, Syed Sulaiman SA, Hassali MA. Linguistic validation of the 5D itching scale to Arabic in patients with end-stage kidney disease. J Ren Care. 2013;39(4):222–7.
Adhikari L, Kayastha R, Bhatta K. Prevalence of uremic pruritus in chronic kidney patients undergoing maintenance hemodialysis at Kathmandu Medical College Teaching Hospital. J Kathmandu Med Coll 2016;5:124–7.
Shirazian S, Aina O, Park Y, et al. Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis 2017;10:11–26.
Simonsen E, Komenda P, Lerner B et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis 2017; 70: 638–655.
Foroutan N, Etminan A, Nikvarz N et al. Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial. Hemodial Int 2017; 21: 63–71
Gobo-Oliveira M, Pigari VG, Ogata MS et al. Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial. Eur J Dermatol 2018; 28: 488–495
Karadag E, Kilic SP, Karatay G et al. Effect of baby oil on pruritus, sleep quality, and quality of life in hemodialysis patients: pretest-post-test model with control groups. Jpn J Nurs Sci 2014; 11: 180–189
Mathur VS, Kumar J, Crawford PW et al. A multicenter, randomized, double-blind, placebo-controlled trial of nalbuphine ER tablets for uremic pruritus. Am J Nephrol 2017;46: 450–458.
Ibrahim MK, Elshahid AR, El Baz TZ et al. Impact of uremic pruritus on quality of life among end stage renal disease patients on dialysis. J Clin Diagn Res 2016; 10:WC01–WC05.
Takahashi N, Yoshizawa T, Kumagai J, Kawanishi H, Tsuchiya S, Moriishi M, Masaki T. Effectiveness of a treatment algorithm for hemodialysis-associated pruritus in terms of changes in medications. Ren Replace Ther. 2021;7(1):1–2.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
